My Blog List

Tuesday, 10 October 2017

Summary:

Report Hive Market Research Released a New Research Report of 126 pages on Title “ Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2017 “with detailed Analysis, Forecast and Strategies.

Do Inquiry and Grab Sample Time and Radiopharmaceuticals in Nuclear Medicine Report@ https://www.reporthive.com/enquiry.php?id=1083481&req_type=smpl

Description:

In this report, the global Radiopharmaceuticals in Nuclear Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Radiopharmaceuticals in Nuclear Medicine in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India


Global Radiopharmaceuticals in Nuclear Medicine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Radiopharmaceuticals in Nuclear Medicine for each application, including
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Other

Make an Enquiry Of report for Discount @ https://www.reporthive.com/enquiry.php?id=1083481&req_type=disc

Major Points Covered in Table of Contents:

1 Radiopharmaceuticals in Nuclear Medicine Market Overview1.1 Product Overview and Scope of Radiopharmaceuticals in Nuclear Medicine
1.2 Radiopharmaceuticals in Nuclear Medicine Segment by Type (Product Category)
1.2.1 Global Radiopharmaceuticals in Nuclear Medicine Production and CAGR (%) Comparison by Type (Product Category)(2012–2022)
1.2.2 Global Radiopharmaceuticals in Nuclear Medicine Production Market Share by Type (Product Category) in 2016
1.2.3 Diagnostic Radiopharmaceuticals
1.2.4 Therapy Radiopharmaceuticals
1.2.5 Enriched Stable Isotopes
1.3 Global Radiopharmaceuticals in Nuclear Medicine Segment by Application
1.3.1 Radiopharmaceuticals in Nuclear Medicine Consumption (Sales) Comparison by Application (2012–2022)
1.3.2 Diagnostic Application
1.3.3 Therapeutic Application
1.3.4 Research
1.3.5 Pharmaceutical
1.3.6 Other
1.4 Global Radiopharmaceuticals in Nuclear Medicine Market by Region (2012–2022)
1.4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size (Value) and CAGR (%) Comparison by Region (2012–2022)
1.4.2 North America Status and Prospect (2012–2022)
1.4.3 Europe Status and Prospect (2012–2022)
1.4.4 China Status and Prospect (2012–2022)
1.4.5 Japan Status and Prospect (2012–2022)
1.4.6 Southeast Asia Status and Prospect (2012–2022)
1.4.7 India Status and Prospect (2012–2022)
1.5 Global Market Size (Value) of Radiopharmaceuticals in Nuclear Medicine (2012–2022)
1.5.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue Status and Outlook (2012–2022)
1.5.2 Global Radiopharmaceuticals in Nuclear Medicine Capacity, Production Status and Outlook (2012–2022)

2 Global Radiopharmaceuticals in Nuclear Medicine Market Competition by Manufacturers2.1 Global Radiopharmaceuticals in Nuclear Medicine Capacity, Production and Share by Manufacturers (2012–2017)
2.1.1 Global Radiopharmaceuticals in Nuclear Medicine Capacity and Share by Manufacturers (2012–2017)
2.1.2 Global Radiopharmaceuticals in Nuclear Medicine Production and Share by Manufacturers (2012–2017)
2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Share by Manufacturers (2012–2017)
2.3 Global Radiopharmaceuticals in Nuclear Medicine Average Price by Manufacturers (2012–2017)
2.4 Manufacturers Radiopharmaceuticals in Nuclear Medicine Manufacturing Base Distribution, Sales Area and Product Type
2.5 Radiopharmaceuticals in Nuclear Medicine Market Competitive Situation and Trends
2.5.1 Radiopharmaceuticals in Nuclear Medicine Market Concentration Rate
2.5.2 Radiopharmaceuticals in Nuclear Medicine Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue (Value) by Region (2012–2017)3.1 Global Radiopharmaceuticals in Nuclear Medicine Capacity and Market Share by Region (2012–2017)
3.2 Global Radiopharmaceuticals in Nuclear Medicine Production and Market Share by Region (2012–2017)
3.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Market Share by Region (2012–2017)
3.4 Global Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012–2017)
3.5 North America Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012–2017)
3.6 Europe Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012–2017)
3.7 China Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012–2017)
3.8 Japan Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012–2017)
3.9 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012–2017)
3.10 India Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Revenue, Price and Gross Margin (2012–2017)
Read Full Table of Contents

About Report Hive Research

We are a leading repository of market research reports and solutions catering to industries like Comm & Technology, Energy & Power, Food And Beverages, Automotive & Transportation, Healthcare & Life Science etc. This large collection of reports assists organizations in decision-making on aspects such as market entry strategies, market sizing, market share analysis, competitive analysis, product portfolio analysis and opportunity analysis among others. We also assist in determining the best suited and targeted report from our large repository of global reports, company-specific reports and country-level reports.

Contact Us

Mike Ross
Marketing Manager
mike.ross@reporthive.com
http://www.reporthive.com
Phone: +1 312–604–7084
Sainath Nagar, Vadgaon Sheri,
Pune, Maharashtra 411014